NMPA Approval

Irbesartan and Hydrochlorothiazide Tablets

Approval Number

国药准字H20113240

Company常山生化药业（江苏）有限公司

Registration Date

March 16, 2021

Previous Approval Numbers

国药准字H20113240

Drug Information

Generic Name

厄贝沙坦氢氯噻嗪片

Dosage Form

片剂

Strength

厄贝沙坦150mg和氢氯噻嗪12.5mg

Drug Type

化学药品

Registration Date

March 16, 2021

Company Information

Applicant Company

Company Name常山生化药业（江苏）有限公司

Company Address

江苏省常州市武进经济开发区果香路18号

Manufacturing Company

Company Name常山生化药业（江苏）有限公司

Company Address

江苏省常州市武进经济开发区果香路18号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

厄贝沙坦氢氯噻嗪片 - NMPA 批准文号 | MedPath